← Open Payments lookup

ALISHA MASON: Open Payments

NPI 1023529443 · RIPLEY, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$774 in 43 payments from 13 companies in 2025. Trend: 2023 $500 · 2024 $444 · 2025 $774

Food & beverage: $774
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP8$152
Bayer Healthcare Pharmaceuticals Inc.5$82
Novo Nordisk Inc5$79
Esperion Therapeutics, Inc.4$72
Amgen Inc.4$65
Lilly USA, LLC4$64
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)3$60
Sumitomo Pharma America, Inc.3$55
GlaxoSmithKline, LLC.2$44
Boehringer Ingelheim Pharmaceuticals, Inc.2$38

Products named: JARDIANCE, FARXIGA, Kerendia, NEXLETOL, CAPLYTA, GEMTESA, Wegovy, TRELEGY ELLIPTA.

Industry payments across MS — which companies pay providers there.